03 / Team & Network
BioXpress brings together an experienced biotechnology team with specialist capability for complex biosimilar programmes.
Team
World-class expertise in biologic development and manufacturing.
CEO & Member of the Board of Directors | PhD, MBA
Gerrit managed the Neurology Business Unit for the blockbuster multiple sclerosis treatment Rebif® at Serono International. He was formerly President of ExcellGene, COO of RiboVax and NatiMab, CSO of Celluris (cell therapies), and co-founder of several start-ups. Gerrit was also a Professor at a University of Applied Sciences.
Chairman of the Board of Directors | PhD
Luc-Alain was at the origin of the analytical testing of biological drugs and has worked on more than 50 biosimilarity and over 100 innovator characterisation packages for clients. He successfully exited his company, MScan.
Member of the Board of Directors | PhD, MBA
During her tenure at Genentech, Cori developed several marketed products, including Kogenate®, Activase®, Herceptin®, Xolair®, Raptiva®, Avastin® and Perjeta®.Network
BioXpress partners with specialist organisations across Switzerland for manufacturing, analytics and technology development.
